Ellevest Inc’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-623
Closed -$42.2K 764
2023
Q1
$42.2K Buy
623
+65
+12% +$4.18K ﹤0.01% 643
2022
Q4
$27.6K Sell
558
-92
-14% -$3.76K ﹤0.01% 765
2022
Q3
$21K Sell
650
-32
-5% -$1.32K ﹤0.01% 803
2022
Q2
$27K Buy
682
+347
+104% +$18.6K ﹤0.01% 701
2022
Q1
$23K Buy
335
+236
+238% +$17.3K ﹤0.01% 704
2021
Q4
$8K Buy
99
+61
+161% +$5.38K ﹤0.01% 895
2021
Q3
$4K Sell
38
-12
-24% -$1.27K ﹤0.01% 1005
2021
Q2
$6K Sell
50
-93
-65% -$11.1K ﹤0.01% 863
2021
Q1
$19K Sell
143
-7
-5% -$958 ﹤0.01% 667
2020
Q4
$20K Buy
+150
New +$18.1K ﹤0.01% 628

Other funds holding EXAS

Ellevest Inc's EXAS Position: Q2 2023 in Review

Ellevest Inc sold out of Exact Sciences (EXAS) in Q2 2023, closing a stake of 623 shares — an estimated $42.2K sold.

Ellevest Inc first reported a position in EXAS in Q4 2020 and held it in 10 quarters. The position peaked at $42.2K in Q1 2023. 653 funds tracked by Wall St. Rank hold EXAS as of Q2 2023.

  • Ellevest Inc reported no remaining Exact Sciences position as of Q2 2023 after selling out during the quarter.
  • Ellevest Inc sold 623 Exact Sciences shares in Q2 2023, an estimated $42.2K.
  • Ellevest Inc first reported a position in Exact Sciences in Q4 2020 and held it in 10 quarters.
  • Ellevest Inc's Exact Sciences position peaked at $42.2K in Q1 2023.
  • 653 funds tracked by Wall St. Rank held Exact Sciences as of Q2 2023.

Based on Ellevest Inc's 13F filing for Q2 2023, filed 9 Aug 2023.